Gene · 2814
Papers2,970
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,970
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A Lipid Nanoparticle-Formulated GP5-mRNA Vaccine Induces PRRSV-Specific Humoral and Cellular Immune Responses in BALB/c Mice. | Vet Sci | 2026 | 42797896 | PubTator, text mining | PubMed |
| Co-Infection of PRRSV-1 and PRRSV-2 in a Single Sow: Complete Genome Characterization Reveals a Novel CH-1a-Backbone Recombinant with an NADC30-Derived Nsp2 in China. | Viruses | 2026 | 42797875 | PubTator, text mining | PubMed |
| Genetic Diversity, Phylogenetic Lineages, and Antigenic Features of the PRRSV-1 GP5 Gene in China. | Microorganisms | 2026 | 42795543 | PubTator, text mining | PubMed |
| Longitudinal Molecular Epidemiology and Genomic Evolution of Porcine Reproductive and Respiratory Syndrome Virus in a Large-Scale Swine Production System in Northern China, 2023-2026. | Transbound Emerg Dis | 2026 | 42768913 | PubTator, text mining | PubMed |
| Oxidative stress induces porcine RCAN1-1L to promote mitophagy and enhance PRRSV replication. | Dev Comp Immunol | 2026 | 42763026 | PubTator, text mining | PubMed |
| CRISPR and yeast two-hybrid screens identify CD81 as a proviral host factor for PRRSV. | J Virol | 2026 | 42734356 | PubTator, text mining | PubMed |
| Effective protection against PRRSV NADC30 by recombinant chimpanzee adenovirus vaccines expressing GP35 or M-GP5 fusion proteins. | Vaccine | 2026 | 42727398 | PubTator, text mining | PubMed |
| Comparative analysis of human papilloma virus detection methods and prognostic significance of transcriptionally active viral load in oropharyngeal squamous cell carcinoma. | Oral Oncol | 2026 | 42696859 | PubTator, text mining | PubMed |
| Development and immunological evaluation of a multi-antigen recombinant adenovirus vaccine candidate against PRRSV and PCV2. | BMC Vet Res | 2026 | 42675487 | PubTator, text mining | PubMed |
| ORF5-based molecular characterization of PRRSV reveals multiple Co-circulating lineages in Vietnam, 2021-2026. | Vet J | 2026 | 42612749 | PubTator, text mining | PubMed |
| Genomic characterization of a NADC30-like PRRSV strain harboring a unique "111+2+1+19" amino acid deletion in NSP2 in northern Xinjiang, China, 2026. | Microb Pathog | 2026 | 42594728 | PubTator, text mining | PubMed |
| Porcine serum amyloid A2 blocks PRRSV by directly targeting virion-associated PIP2 and GP5. | Antiviral Res | 2026 | 42571791 | PubTator, text mining | PubMed |
| The S32 amino acid deletion in the GP5 protein modulates the infectivity of porcine reproductive and respiratory syndrome virus. | Virulence | 2026 | 42559914 | PubTator, text mining | PubMed |
| MARCH8 inhibits PRRSV-2 replication by targeting viral GP5 for proteasomal degradation at a conserved lysine 163. | Vet Microbiol | 2026 | 42556151 | PubTator, text mining | PubMed |
| Genetic Evolution and Molecular Characterization of PRRSV GP5 in Germany. | Vet Sci | 2026 | 42514692 | PubTator, text mining | PubMed |
| Translating viral genetic data to PRRSV-2 cross-neutralization using machine learning. | Front Immunol | 2026 | 42500660 | PubTator, text mining | PubMed |
| EscaPRRS-ORF5: a structure-aware evolutionary framework for prioritizing immune escape-prone variants in porcine reproductive and respiratory syndrome virus. | Bioinformatics | 2026 | 42489519 | PubTator, text mining | PubMed |
| Cardiac remodelling and dysfunction in cancer patients receiving cardiotoxic therapies: proteomic and metabolomic profiling. | Eur Heart J | 2026 | 42366805 | PubTator, text mining | PubMed |
| Pathological Predictors of Limited Salvage Radiotherapy Efficacy After Radical Prostatectomy: Central Review of JCOG0401. | Cancers (Basel) | 2026 | 42352403 | PubTator, text mining | PubMed |
| Signal peptide cleavage and ectodomain regions of GP2 are required for PRRSV infection. | J Gen Virol | 2026 | 42313464 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2814/papers